Search Results 1-10 of 11350 for Ibrance

  1. Palbociclib (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Ibrance. Descriptions. Palbociclib is used to treat hormone ...

  2. Palbociclib (Oral Route) Proper Use - Mayo Clinic

    Your doctor may also give you other medicines (eg, luteinizing hormone-releasing hormone agonists) in combination with palbociclib plus letrozole or fulvestrant ...

  3. Breast Cancer: PROMISE Study - Center for Individualized Medicine - Mayo Clinic Research

    Endocrine resistance is common in patients with breast cancer, and while the drug palbociclib (Ibrance) in combination with endocrine therapy has provided ...

  4. Side Effects - Palbociclib (Oral Route)

    Black, tarry stools · bleeding gums · blood in the urine or stools · chest pain · chills · cough · difficulty breathing · fever ...

  5. Clinical Studies - Center for Individualized Medicine

    ... (Ibrance) and endocrine therapy. Other aims are to discover microbiome-based biomarkers of treatment response, to evaluate drug response phenotypes using ...

  6. Cancer fatigue: Why it occurs and how to cope - Mayo Clinic

    Most people with cancer have fatigue. Find out what cancer-related fatigue feels like and when it's concerning. Learn ways to cope with fatigue.

  7. Mouth sores caused by cancer treatment: How to cope - Mayo Clinic

    In general, cancer treatments that can cause mouth sores include: Chemotherapy; Radiation therapy aimed at the head and neck; Bone marrow transplant, also known ...

  8. Chemotherapy and sex: Is sexual activity OK during treatment? - Mayo Clinic

    Is it safe to have sex while undergoing chemotherapy? · What type of cancer do you have? Cancers of the genital tract, urinary tract, anus or rectum may require ...

  9. Breast cancer - Diagnosis and treatment - Mayo Clinic

    A mammogram is an X-ray of the breast tissue. Mammograms are commonly used to screen for breast cancer. If a screening mammogram finds something concerning, you ...

  10. A Study of Using Palbociclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive/ Human Epidermal Growth Factor Receptor 2 Negative Early Breast Cancer - Mayo Clinic

    The purpose of this study is to evaluate the addition of 2 years of palbociclib to standard adjuvant endocrine therapy for patients with HR+ / HER2- early ...